IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating β-catenin
2021 · Translational Oncology · 37 citations
https://doi.org/10.1016/j.tranon.2021.101059
Q
Qiang Du
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
76
Papers
1.9K
Citations
23
h-index
32
i10-index
Qiang Du is an academic researcher from Tongji University. The author has contributed to research in topics: Cancer-related molecular mechanisms research & MicroRNA in disease regulation & Wnt/β-catenin signaling in development and cancer. The author has an h-index of 23, co-authored 65 publications.
ORCID: 0009-0003-7172-5682Papers by this author
worksInterferon regulatory factor 1 (IRF-1) downregulates Checkpoint kinase 1 (CHK1) through miR-195 to upregulate apoptosis and PD-L1 expression in Hepatocellular carcinoma (HCC) cells
2021 · British Journal of Cancer · 34 citations
https://doi.org/10.1038/s41416-021-01337-6
MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1
2020 · Biochemical and Biophysical Research Communications · 16 citations
https://doi.org/10.1016/j.bbrc.2020.01.034
Pancreatic sarcoidosis: A case report and literature review
2025 · Medicine · 1 citations
https://doi.org/10.1097/md.0000000000041957
MYB proto-oncogene like 2 promotes hepatocellular carcinoma growth and glycolysis via binding to the <i>Optic atrophy 3</i> promoter and activating its expression
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19195396
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat